SLC12A5 and epilepsy: The critical role of KCC2 function and neuro-immune interactions via C1q in regulating apoptosis following seizures will help promote the development of potential immune-based therapeutic applications to alleviate neuronal damage in epilepsy, and aid the production and evaluation of the novel KCC2 activator therapeutic class.